bluebird bio (BLUE) Posts Wider-than-Expected Q3 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
bluebird bio Reports Third Quarter 2015 Financial Results and Recent Operational Progress
November 4, 2015 4:09 PM EST-- Six abstracts accepted for presentation at American Society of Hematology (ASH) Annual Meeting --
-- Increased enrollment target for HGB-206 study of LentiGlobin® in severe sickle cell disease (SCD) from eight patients to 20 patients -
-- Published a paper on megaTAL genome editing platform in Science Translational Medicine with collaborators at Seattle Childrens Research Institute --
-- Ended quarter with $901.7 million in cash, cash equivalents, and marketable securities --
-- Company will discuss ASH... More
